(Q47372080)

English

Effect of rosiglitazone on cardiac electrophysiology, infarct size and mitochondrial function in ischaemia and reperfusion of swine and rat heart.

scientific article published on 10 June 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21666037%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Effect of rosiglitazone on cardiac electrophysiology, infarct size and mitochondrial function in ischaemia and reperfusion of swine and rat heart (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21666037%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

electrophysiology

1 reference

based on heuristic

inferred from title

(RS)-rosiglitazone

1 reference

based on heuristic

inferred from title

Punate Weerateerangkul

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21666037%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

author name string

Siripong Palee

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21666037%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Sirirat Surinkeaw

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21666037%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Siriporn Chattipakorn

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21666037%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Nipon Chattipakorn

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21666037%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

publication date

10 June 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21666037%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

Experimental Physiology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21666037%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

96

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21666037%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21666037%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

778-789

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21666037%20AND%20SRC:MED&resulttype=core&format=json

4 February 2020

From mitochondrial dynamics to arrhythmias.

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

Apoptotic signaling cascades.

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

Effects of chronic PPAR-agonist treatment on cardiac structure and function, blood pressure, and kidney in healthy sprague-dawley rats

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

A retrospective evaluation of congestive heart failure and myocardial ischemia events in 14,237 patients with type 2 diabetes mellitus enrolled in 42 short-term, double-blind, randomized clinical studies with rosiglitazone

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

An introduction to the molecular mechanisms of apoptosis

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

Uncertain effects of rosiglitazone on the risk for myocardial infarction and cardiovascular death

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

Effect of peroxisome proliferator-activated receptor gamma ligand. Rosiglitazone on left ventricular remodeling in rats with myocardial infarction

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

Cardioprotection mediated by rosiglitazone, a peroxisome proliferator-activated receptor gamma ligand, in relation to nitric oxide

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

Peroxisome proliferator-activated receptor gamma as a drug target in the pathogenesis of insulin resistance

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

Granulocyte colony-stimulating factor stabilizes cardiac electrophysiology and decreases infarct size during cardiac ischaemic/reperfusion in swine.

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

Thiazolidinedione drugs and cardiovascular risks: a science advisory from the American Heart Association and American College Of Cardiology Foundation

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

Rosiglitazone, a peroxisome proliferator-activated receptor-gamma, inhibits the Jun NH(2)-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injury

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

Rosiglitazone improves myocardial glucose uptake in patients with type 2 diabetes and coronary artery disease: a 16-week randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

Effect of rosiglitazone on cardiac fibroblast proliferation, nitric oxide production and connective tissue growth factor expression induced by advanced glycation end-products

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

Thiazolidinediones and cardiovascular outcomes in older patients with diabetes

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

Anti-apoptotic effects of rosiglitazone in hypercholesterolemic rabbits subjected to myocardial ischemia and reperfusion

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

Mitochondrial oxidant stress triggers cell death in simulated ischemia-reperfusion.

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

Thiazolidinedione drugs block cardiac KATP channels and may increase propensity for ischaemic ventricular fibrillation in pigs

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

The PPARgamma-activator rosiglitazone does not alter remodeling but increases mortality in rats post-myocardial infarction

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

Cardioprotective effects of rosiglitazone are associated with selective overexpression of type 2 angiotensin receptors and inhibition of p42/44 MAPK.

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

Winners and losers at the rosiglitazone gamble A meta-analytical approach at the definition of the cardiovascular risk profile of rosiglitazone

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

Insulin sensitizing pharmacotherapy for prevention of myocardial infarction in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

The antidiabetic agent rosiglitazone upregulates SERCA2 and enhances TNF-alpha- and LPS-induced NF-kappaB-dependent transcription and TNF-alpha-induced IL-6 secretion in ventricular myocytes

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

Thiazolidinedione treatment normalizes insulin resistance and ischemic injury in the zucker Fatty rat heart.

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

Adiponectin: an indispensable molecule in rosiglitazone cardioprotection following myocardial infarction

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

Inflammation and myocardial infarction

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

Peroxisome proliferator-activated receptor gamma agonist improves arterial stiffness in patients with type 2 diabetes mellitus and coronary artery disease

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

Rosiglitazone treatment in Zucker diabetic Fatty rats is associated with ameliorated cardiac insulin resistance and protection from ischemia/reperfusion-induced myocardial injury

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

Rosiglitazone-induced myocardial protection against ischaemia-reperfusion injury is mediated via a phosphatidylinositol 3-kinase/Akt-dependent pathway.

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2011.057885

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47372080&oldid=1512250792"